Covered recipient · General Payments record
JAMES T CHAPMAN
Allopathic & Osteopathic Physicians Dermatology MOHS-Micrographic Surgery
General Payments · PY2018–2024
$3,846.79
- Reported across 146 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $751.07 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $311.94 | 17 |
| Lilly USA, LLC | $142.77 | 2 |
| Dermavant Sciences, Inc. | $141.72 | 3 |
| Regeneron Healthcare Solutions, Inc. | $53.16 | 2 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $24.42 | 1 |
| Amgen Inc. | $20.90 | 1 |
| Arcutis Biotherapeutics, Inc. | $20.48 | 1 |
| Galderma Laboratories, L.P. | $19.21 | 1 |
| PFIZER INC. | $16.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $0.66 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444180 | CMS |
| ABBVIE INC. | $25.79 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444182 | CMS |
| ABBVIE INC. | $22.95 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444184 | CMS |
| ABBVIE INC. | $11.69 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444186 | CMS |
| ABBVIE INC. | $21.44 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444188 | CMS |
| ABBVIE INC. | $19.29 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444190 | CMS |
| ABBVIE INC. | $21.36 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444192 | CMS |
| ABBVIE INC. | $24.75 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444194 | CMS |
| ABBVIE INC. | $16.76 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444196 | CMS |
| ABBVIE INC. | $6.17 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444198 | CMS |
| ABBVIE INC. | $13.08 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444200 | CMS |
| ABBVIE INC. | $21.13 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444202 | CMS |
| ABBVIE INC. | $27.82 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444204 | CMS |
| ABBVIE INC. | $14.80 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444206 | CMS |
| ABBVIE INC. | $19.78 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444208 | CMS |
| ABBVIE INC. | $23.35 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444210 | CMS |
| ABBVIE INC. | $21.12 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103444212 | CMS |
| Amgen Inc. | $20.90 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117221833 | CMS |
| Arcutis Biotherapeutics, Inc. | $20.48 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121050839 | CMS |
| Dermavant Sciences, Inc. | $16.97 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127856953 | CMS |
| Dermavant Sciences, Inc. | $117.56 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127856955 | CMS |
| Dermavant Sciences, Inc. | $7.19 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127856957 | CMS |
| Galderma Laboratories, L.P. | $19.21 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145290048 | CMS |
| Lilly USA, LLC | $120.88 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135047152 | CMS |
| Lilly USA, LLC | $21.89 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135026316 | CMS |
| PFIZER INC. | $16.47 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131742164 | CMS |
| Regeneron Healthcare Solutions, Inc. | $26.19 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114022054 | CMS |
| Regeneron Healthcare Solutions, Inc. | $26.97 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114022056 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $24.42 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152155601 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.